| |
| |
|
| Insider
Information: |
Ecor1 Capital, Llc |
| Relationship: |
10% Owner |
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
13 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
241,705,546 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$1,094,335,331 |
|
|
| Total
Shares |
241,705,546 |
|
|
| Total
Value |
$1,094,335,331 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
15
|
10
|
|
Stock
price went up :
|
15
|
4
|
| Stock
price went down : |
0
|
6
|
| |
|
|
|
Gain/Loss Ratio : |
15.0
|
15.0
|
| Percentage
Gain/Loss : |
 92.6%
|
 -63.1%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Celladon Corp |
CLDN |
10% Owner |
|
0 |
2015-06-26 |
2,843,170 |
Premium* |
|
|
Prothena Corp Plc |
PRTA |
10% Owner |
|
0 |
2022-05-05 |
11,584,280 |
Premium* |
|
|
Surface Oncology, Inc. |
SURF |
10% Owner |
|
0 |
2020-09-01 |
4,701,081 |
Premium* |
|
|
Akouos, Inc. |
AKUS |
10% Owner |
2020-06-30 |
0 |
2020-06-30 |
1,975,984 |
Premium* |
|
|
Anaptysbio Inc |
ANAB |
10% Owner |
|
0 |
2021-03-09 |
7,151,624 |
Premium* |
|
|
Corvus Pharmaceuticals, Inc. |
CRVS |
10% Owner |
|
0 |
2021-10-01 |
81,077 |
Premium* |
|
|
Odonate Therapeutics Inc |
ODT |
10% Owner |
|
0 |
2021-12-10 |
0 |
Premium* |
|
|
Voyager Therapeutics, Inc. |
VYGR |
10% Owner |
|
0 |
2023-01-11 |
3,851,507 |
Premium* |
|
|
Tscan Therapeutics, Inc. |
TCRX |
10% Owner |
|
0 |
2023-05-26 |
5,000,000 |
Premium* |
|
|
Mersana Therapeutics, Inc. |
MRSN |
10% Owner |
|
0 |
2023-07-27 |
19,364,688 |
Premium* |
|
|
Tango Therapeutics Ord Shs |
TNGX |
10% Owner |
|
0 |
2023-10-13 |
13,330,736 |
Premium* |
|
|
Mirati Therapeutics, Inc. |
MRTX |
10% Owner |
|
0 |
2023-12-18 |
7,396,979 |
Premium* |
|
|
Adaptimmune Therapeutics PLC |
ADAP |
10% Owner |
|
0 |
2024-03-08 |
164,424,420 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ADAP |
Adaptimmune Therapeutics ... |
10% Owner |
– – • |
2024-03-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
164,424,420 |
|
% |
|
| MRTX |
Mirati Therapeutics, Inc. |
10% Owner |
– – • |
2023-12-18 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
7,396,979 |
|
% |
|
| TNGX |
Tango Therapeutics Ord Sh... |
10% Owner |
– – • |
2023-10-13 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
13,330,736 |
|
- |
|
| MRSN |
Mersana Therapeutics, Inc... |
10% Owner |
– – • |
2023-07-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
19,364,688 |
|
% |
|
| TCRX |
Tscan Therapeutics, Inc. |
10% Owner |
– – • |
2023-05-26 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,000,000 |
|
- |
|
| VYGR |
Voyager Therapeutics, Inc... |
10% Owner |
– – • |
2023-01-11 |
4 |
S |
$8.50 |
$934,615 |
I/I |
(110,000) |
3,851,507 |
0 |
% |
|
| VYGR |
Voyager Therapeutics, Inc... |
10% Owner |
– – • |
2023-01-10 |
4 |
S |
$8.05 |
$2,709,433 |
I/I |
(336,400) |
3,961,507 |
0 |
% |
|
| VYGR |
Voyager Therapeutics, Inc... |
10% Owner |
– – • |
2023-01-09 |
4 |
S |
$7.67 |
$3,498,295 |
I/I |
(456,000) |
4,297,907 |
0 |
% |
|
| VYGR |
Voyager Therapeutics, Inc... |
10% Owner |
– – • |
2022-06-23 |
4 |
B |
$5.66 |
$2,126,543 |
I/I |
376,000 |
4,753,907 |
1.5 |
% |
|
| VYGR |
Voyager Therapeutics, Inc... |
10% Owner |
– – • |
2022-06-21 |
4 |
B |
$5.28 |
$535,504 |
I/I |
101,400 |
4,377,907 |
1.5 |
% |
|
| PRTA |
Prothena Corp Plc |
10% Owner |
– – • |
2022-05-05 |
4 |
S |
$29.02 |
$30,840,599 |
I/I |
(1,062,736) |
11,584,280 |
0 |
% |
|
| PRTA |
Prothena Corp Plc |
10% Owner |
– – • |
2022-05-05 |
4 |
B |
$29.02 |
$30,840,599 |
I/I |
1,062,736 |
11,584,280 |
1.5 |
% |
|
| VYGR |
Voyager Therapeutics, Inc... |
10% Owner |
– – • |
2022-04-21 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,276,507 |
|
% |
|
| PRTA |
Prothena Corp Plc |
10% Owner |
– – • |
2022-01-12 |
4 |
B |
$37.50 |
$11,250,300 |
I/I |
300,000 |
11,584,280 |
1.5 |
% |
|
| ODT |
Odonate Therapeutics Inc |
10% Owner |
– – • |
2021-12-10 |
4 |
S |
$1.55 |
$9,147,421 |
I/I |
(5,545,000) |
0 |
0 |
% |
|
| ODT |
Odonate Therapeutics Inc |
10% Owner |
– – • |
2021-12-09 |
4 |
S |
$1.82 |
$284,981 |
I/I |
(156,669) |
5,545,000 |
0 |
% |
|
| ODT |
Odonate Therapeutics Inc |
10% Owner |
– – • |
2021-12-01 |
4 |
S |
$1.66 |
$308,662 |
I/I |
(185,941) |
5,701,669 |
0 |
% |
|
| ODT |
Odonate Therapeutics Inc |
10% Owner |
– – • |
2021-12-01 |
4 |
B |
$1.66 |
$308,662 |
I/I |
185,941 |
5,701,669 |
1.5 |
% |
|
| ODT |
Odonate Therapeutics Inc |
10% Owner |
– – • |
2021-11-17 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,701,669 |
|
% |
|
| CRVS |
Corvus Pharmaceuticals, I... |
10% Owner |
– – • |
2021-10-01 |
4 |
S |
$4.96 |
$9,928,800 |
I/I |
(2,000,000) |
81,077 |
0 |
% |
|
| CRVS |
Corvus Pharmaceuticals, I... |
10% Owner |
– – • |
2021-09-30 |
4 |
S |
$5.04 |
$15,131,100 |
I/I |
(3,000,000) |
2,081,077 |
0 |
% |
|
| CRVS |
Corvus Pharmaceuticals, I... |
10% Owner |
– – • |
2021-09-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,081,077 |
|
% |
|
| PRTA |
Prothena Corp Plc |
10% Owner |
– – • |
2021-06-18 |
4 |
OE |
$30.00 |
$7,500,000 |
I/I |
250,000 |
11,284,280 |
0 |
- |
|
| PRTA |
Prothena Corp Plc |
10% Owner |
– – • |
2021-03-24 |
4 |
B |
$20.75 |
$18,156,250 |
I/I |
875,000 |
11,034,280 |
1.5 |
% |
|
| ANAB |
Anaptysbio Inc |
10% Owner |
– – • |
2021-03-09 |
4 |
B |
$18.70 |
$9,928,426 |
I/I |
531,000 |
7,151,624 |
1.5 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
